AN2 Therapeutics, Inc. ANTX
4.18 USD -0.17 (-3.91%)
At closeNov 3, 2026, 4:01 PM EST
4.18 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
4.10 Day range 4.55
1.03 52-week range 6.28
- YTD
- +266.67%
- 1 year
- +263.48%
Analyst view
Price target (mean) 2.67 -36.2% downside
Now 4.18
- Target (low)
- 1.00
- Target (mean)
- 2.67
- Target (high)
- 5.00
Ratings (0m) 5 1 buy · 3 hold · 1 sell
- Strong buy1
- Buy0
- Hold3
- Sell1
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.26 | -0.34 – -0.20 | -0.57 | +54.4% | 0 | 0.0% | 3 |
| Next quarter | -0.235 | -0.25 – -0.22 | -0.56 | +58.0% | 0 | 0.0% | 2 |
| Current year | -1.45 | -1.45 – -1.45 | -2.74 | +47.1% | 0 | 0.0% | 1 |
| Next year | -1.16 | -1.44 – -1.00 | -1.45 | +19.8% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 19, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Nov 18, 2024 | TD Cowen | Downgrade | Buy | Hold |
| Aug 9, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jul 3, 2024 | Leerink Partners | Upgrade | Market Perform | Outperform |
| May 16, 2024 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Apr 2, 2024 | JMP Securities | Upgrade | Market Perform | Market Outperform |
| Apr 1, 2024 | Oppenheimer | Reiterated | Perform | Perform |
| Feb 13, 2024 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Feb 12, 2024 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Feb 12, 2024 | Oppenheimer | Downgrade | Outperform | Perform |
| Feb 12, 2024 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Jan 4, 2024 | JMP Securities | Initiated | — | Market Outperform |
| Mar 30, 2023 | Oppenheimer | Maintained | — | Outperform |
| Nov 14, 2022 | SVB Leerink | Maintained | — | Outperform |
| Apr 19, 2022 | Evercore ISI Group | Initiated | — | Outperform |
| Apr 19, 2022 | Oppenheimer | Initiated | — | Outperform |
| Apr 19, 2022 | Cowen & Co. | Initiated | — | Outperform |